BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17529993)

  • 1. SET and PARP1 remove DEK from chromatin to permit access by the transcription machinery.
    Gamble MJ; Fisher RP
    Nat Struct Mol Biol; 2007 Jun; 14(6):548-55. PubMed ID: 17529993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
    Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
    PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inheritance of silent rDNA chromatin is mediated by PARP1 via noncoding RNA.
    Guetg C; Scheifele F; Rosenthal F; Hottiger MO; Santoro R
    Mol Cell; 2012 Mar; 45(6):790-800. PubMed ID: 22405650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
    Sandén C; Järvstråt L; Lennartsson A; Brattås PL; Nilsson B; Gullberg U
    Mol Cancer; 2014 Sep; 13():215. PubMed ID: 25216995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
    Kappes F; Fahrer J; Khodadoust MS; Tabbert A; Strasser C; Mor-Vaknin N; Moreno-Villanueva M; Bürkle A; Markovitz DM; Ferrando-May E
    Mol Cell Biol; 2008 May; 28(10):3245-57. PubMed ID: 18332104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates.
    Gamble MJ; Erdjument-Bromage H; Tempst P; Freedman LP; Fisher RP
    Mol Cell Biol; 2005 Jan; 25(2):797-807. PubMed ID: 15632079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length.
    Fahrer J; Popp O; Malanga M; Beneke S; Markovitz DM; Ferrando-May E; Bürkle A; Kappes F
    Biochemistry; 2010 Aug; 49(33):7119-30. PubMed ID: 20669926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.
    Karam M; Thenoz M; Capraro V; Robin JP; Pinatel C; Lancon A; Galia P; Sibon D; Thomas X; Ducastelle-Lepretre S; Nicolini F; El-Hamri M; Chelghoun Y; Wattel E; Mortreux F
    Neoplasia; 2014 Jan; 16(1):21-30. PubMed ID: 24563617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP1 enhances inflammatory cytokine expression by alteration of promoter chromatin structure in microglia.
    Martínez-Zamudio RI; Ha HC
    Brain Behav; 2014 Jul; 4(4):552-65. PubMed ID: 25161822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of the DEK protein in mammalian chromatin.
    Hu HG; Scholten I; Gruss C; Knippers R
    Biochem Biophys Res Commun; 2007 Jul; 358(4):1008-14. PubMed ID: 17524367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PML-associated protein DEK regulates the balance of H3.3 loading on chromatin and is important for telomere integrity.
    Ivanauskiene K; Delbarre E; McGhie JD; Küntziger T; Wong LH; Collas P
    Genome Res; 2014 Oct; 24(10):1584-94. PubMed ID: 25049225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Complexity of DEK Signaling in Cancer Progression.
    Teng Y; Lang L; Jauregui CE
    Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK.
    Ko SI; Lee IS; Kim JY; Kim SM; Kim DW; Lee KS; Woo KM; Baek JH; Choo JK; Seo SB
    FEBS Lett; 2006 May; 580(13):3217-22. PubMed ID: 16696975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histone chaperone, DEK, transcriptionally coactivates a nuclear receptor.
    Sawatsubashi S; Murata T; Lim J; Fujiki R; Ito S; Suzuki E; Tanabe M; Zhao Y; Kimura S; Fujiyama S; Ueda T; Umetsu D; Ito T; Takeyama K; Kato S
    Genes Dev; 2010 Jan; 24(2):159-70. PubMed ID: 20040570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK.
    Kappes F; Damoc C; Knippers R; Przybylski M; Pinna LA; Gruss C
    Mol Cell Biol; 2004 Jul; 24(13):6011-20. PubMed ID: 15199154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) polymerase 1 regulates activity of DNA polymerase beta in long patch base excision repair.
    Sukhanova M; Khodyreva S; Lavrik O
    Mutat Res; 2010 Mar; 685(1-2):80-9. PubMed ID: 19703477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p300/CBP-associated factor drives DEK into interchromatin granule clusters.
    Cleary J; Sitwala KV; Khodadoust MS; Kwok RP; Mor-Vaknin N; Cebrat M; Cole PA; Markovitz DM
    J Biol Chem; 2005 Sep; 280(36):31760-7. PubMed ID: 15987677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEK over-expression promotes mitotic defects and micronucleus formation.
    Matrka MC; Hennigan RF; Kappes F; DeLay ML; Lambert PF; Aronow BJ; Wells SI
    Cell Cycle; 2015; 14(24):3939-53. PubMed ID: 25945971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial Growth Inhibition Screen (BGIS) identifies a loss-of-function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin.
    Guo H; Prell M; Königs H; Xu N; Waldmann T; Hermans-Sachweh B; Ferrando-May E; Lüscher B; Kappes F
    FEBS Lett; 2021 May; 595(10):1438-1453. PubMed ID: 33686684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drosophila histone H2A variant (H2Av) controls poly(ADP-ribose) polymerase 1 (PARP1) activation in chromatin.
    Kotova E; Lodhi N; Jarnik M; Pinnola AD; Ji Y; Tulin AV
    Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6205-10. PubMed ID: 21444826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.